Renalytix announced the successful completion of $30.0 million financing package
CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS
Taylor Randall inaugurated as President of University of Utah
Funding to Enable Continued Development of Precision Metagenomics Advancing Platform
Donates Monetary Winnings to Biohive’s Non Profit Work to Bring STEM Education to Underrepresented Communities
SINTX Technologies announced a Phase 1 grant of $300k awarded by the National Institutes of Health (NIH) to develop, design and characterize 3D printed implants for craniomaxillofacial (CMF) applications using a composite of silicon nitride and polyetherketoneketone (SN-PEKK).
Results show significant survival benefit in participants who entered open-label extension of study of CNM-Au8®, a gold nanocrystal suspension, compared to validated ENCALS prediction mode
Fresenius Medical Care participates in three-way merger to create premier value-based kidney care provider in the U.S.
The Biden Administration’s Investment in Pandemic Preparedness and Biodefense in the FY 2023 President’s Budget
Diversified Medical Healthcare Acquires Utah Lab, Dynasty Medical Laboratory Services
Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes
Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors